Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Current Assets (2020 - 2025)

Historic Current Assets for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $283.9 million.

  • RxSight's Current Assets fell 100.81% to $283.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $283.9 million, marking a year-over-year decrease of 100.81%. This contributed to the annual value of $293.8 million for FY2024, which is 7447.2% up from last year.
  • As of Q3 2025, RxSight's Current Assets stood at $283.9 million, which was down 100.81% from $283.9 million recorded in Q2 2025.
  • In the past 5 years, RxSight's Current Assets registered a high of $293.8 million during Q4 2024, and its lowest value of $75.5 million during Q2 2021.
  • Moreover, its 5-year median value for Current Assets was $178.4 million (2021), whereas its average is $200.8 million.
  • As far as peak fluctuations go, RxSight's Current Assets surged by 11631.29% in 2021, and later tumbled by 2531.66% in 2022.
  • Quarter analysis of 5 years shows RxSight's Current Assets stood at $176.3 million in 2021, then decreased by 23.68% to $134.6 million in 2022, then increased by 25.16% to $168.4 million in 2023, then soared by 74.47% to $293.8 million in 2024, then dropped by 3.39% to $283.9 million in 2025.
  • Its Current Assets stands at $283.9 million for Q3 2025, versus $283.9 million for Q2 2025 and $288.4 million for Q1 2025.